TY - JOUR
T1 - Peripheral nervous system hyperexcitability in VV2 sporadic Creutzfeldt-Jakob disease
AU - Ong, Charlene J.
AU - Al-Lozi, Muhammad
AU - Cimino, Patrick J.
AU - Bucelli, Robert
N1 - Publisher Copyright:
© 2015 American Academy of Neurology.
PY - 2015/8/19
Y1 - 2015/8/19
N2 - Summary Creutzfeldt-Jakob disease (CJD) is a fatal, rapidly progressive neurodegenerative disease. Most cases are sporadic (sCJD). The pathogenesis of sCJD is associated with a conformational change in abnormal prion protein causing widespread neuronal degeneration, and clinical manifestations can be quite protean. Peripheral nerve hyperexcitability syndrome (PNHS) is rarely associated with CJD and is more commonly associated with autoimmune/paraneoplastic syndromes associated with antibodies against the voltage-gated potassium channel complex (VGKC-Abs). Reports of PNHS in CJD are rare. We report 2 patients with progressive cognitive decline in the setting of peripheral nerve hyperexcitability on electrodiagnostic testing. In both patients VGKC-Abs were negative, and autopsy confirmed that both had sCJD, VV2 subtype. While uncommon, it is important to consider sCJD in patients presenting with PNHS and rapidly progressive dementia.
AB - Summary Creutzfeldt-Jakob disease (CJD) is a fatal, rapidly progressive neurodegenerative disease. Most cases are sporadic (sCJD). The pathogenesis of sCJD is associated with a conformational change in abnormal prion protein causing widespread neuronal degeneration, and clinical manifestations can be quite protean. Peripheral nerve hyperexcitability syndrome (PNHS) is rarely associated with CJD and is more commonly associated with autoimmune/paraneoplastic syndromes associated with antibodies against the voltage-gated potassium channel complex (VGKC-Abs). Reports of PNHS in CJD are rare. We report 2 patients with progressive cognitive decline in the setting of peripheral nerve hyperexcitability on electrodiagnostic testing. In both patients VGKC-Abs were negative, and autopsy confirmed that both had sCJD, VV2 subtype. While uncommon, it is important to consider sCJD in patients presenting with PNHS and rapidly progressive dementia.
UR - http://www.scopus.com/inward/record.url?scp=84939561480&partnerID=8YFLogxK
U2 - 10.1212/CPJ.0000000000000160
DO - 10.1212/CPJ.0000000000000160
M3 - Article
C2 - 29443232
AN - SCOPUS:84939561480
SN - 2163-0402
VL - 5
SP - 326
EP - 332
JO - Neurology: Clinical Practice
JF - Neurology: Clinical Practice
IS - 4
ER -